Recombinant TARDBP antibody (pSer409, pSer410)
Quick Overview for Recombinant TARDBP antibody (pSer409, pSer410) (ABIN7938522)
Target
See all TARDBP AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- pSer409, pSer410
-
Purpose
- TDP43 phospho Ser409/410 antibody (rAb), 100 μg (Clone 6M10)
-
Purification
- Protein A Chromatography
-
Immunogen
- This information is proprietary to Active Motif and/or its suppliers.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:5000-1:50000 dilution
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Purified IgG in PBS, pH 7.3, with 50 % glycerol and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions,Keep all reagents on ice when not in storage
-
Storage
- -20 °C
-
Storage Comment
- Some products may be shipped at room temperature. This will not affect their stability or performance. Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions for storage at -20°C for up to 2 years. Keep all reagents on ice when not in storage.
-
Expiry Date
- 24 months
-
-
- TARDBP (TAR DNA Binding Protein (TARDBP))
-
Alternative Name
- TDP43
-
Background
- TDP-43) was first isolated as a transcriptional inactivator binding to the TAR DNA element of the HIV-1 virus. Neumann et al. (2006) found that a hyperphosphorylated, ubiquitinated, and cleaved form of TARDBP, known as pathologic TDP-43, is the major component of the tau-negative and ubiquitin-positive inclusions that characterize amyotrophic lateral sclerosis (ALS) and the most common pathological subtype of frontotemporal lobar degeneration (FTLD-U).
-
Molecular Weight
- 43 kDa
-
NCBI Accession
- NM_007375
-
Pathways
- Positive Regulation of Peptide Hormone Secretion
Target
-